The April 2020 issue of the Temple Chamber of Commerce Newsletter, Focus on Business, includes a brief retrospective on MR3’s participation in the Temple Health and Bioscience District’s Annual MedTech Startup Symposium and Pitch Competition. The following appears on page 7 of the newsletter, under the subheading, Monitoring MedTech Advancements in Temple:
In 2019, Stan Marett, President of MR3 Health, Inc., met THBD Executive Director Tami Annable at THBD’s Annual MedTech Startup Symposium and Pitch Competition. Marett opted to attend the annual symposium and participate in the pitch competition. During this competition in Temple, individuals were given five minutes to present a new product they hope to bring to market. The judging panel of entrepreneurs, healthcare and medical device experts awarded Marett and MR3 Health third place in the competition.
After the competition, Marett wanted to learn more about what the only taxpayer-funded nonprofit bioscience incubator in Texas has to offer. During a tour, he realized THBD’s proximity to the U.S. Department of Veteran’s Affairs (VA) and Baylor Scott and White made the incubator an ideal place for MR3 Health.
Designed to help proactively connect physicians and patients through remote patient monitoring (RPM) devices, MR3 Health aims to prevent complications associated with chronic illnesses such as diabetes, hypertension and congestive heart failure. The devices monitor patients daily to identify and communicate alerts to the patient and their healthcare provider to indicate the possibility of a high-risk event.
Now a tenant at THBD, Marett hopes to work with doctors and patients in the Temple area to provide RPM services and create a strategic relationship with Baylor Scott and White that can be replicated in other areas. Additionally, MR3 Health aims to engage with the VA for studies that can help to improve new products and services.
In December 2019, MR3 Health was recognized as a “Top 10 Patient Monitoring Pioneer” by MD Tech Review. This national distinction recognized MR3’s foot sensor, TempTouch™ infrared dermal thermometer. The device takes temperature readings and uploads them to cloud-based technology to track changes and alert physicians of any problems. Marett and his team optimized the product for today’s market by enabling Bluetooth technology and a smartphone app to make the technology accessible and effortless for patients to use.
While offering financially accessible products for patients and providers is topof-mind, so is patient compliance. Readings are only measurable if taken by the patient. Rather than relying on patients to remember to check their readings, MR3 Health pings patients who miss a daily reading and transmits early alerts to clinicians.
“We are partners in healthcare,” says Marett. “As we grow, we will continue to ensure patients have accessible tools to track their own health and improve their outcomes. We look forward to continuing our research and building upon valuable partnerships in Temple to help patients and providers manage care effectively. We are excited to be part of the Temple Health and Bioscience ecosystem. We look forward to growing our presence in Temple.”
Download a full copy of the April issue of Focus on Business.